Patents by Inventor Steven Read

Steven Read has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8891743
    Abstract: In one implementation, a method for implementing gain control enhancement for modulated communications includes establishing a communication session between a first endpoint and a second endpoint. The communication session involves forwarding a call signal using an initial gain level until a state transition is detected in the communication session at a digital signal processor. The detection may occur in a transmitting gateway associated with the first endpoint or a receiving gateway associated with the second endpoint. The state transition indicates modulated communications, which may include fax, modem, or text telephony. For example, communication session may be fax over IP (FoIP). The call signal is forwarded using an adjusted gain level based on the state transition. The adjusted gain level may be selected to avoid clipping in the call signal.
    Type: Grant
    Filed: October 4, 2011
    Date of Patent: November 18, 2014
    Assignee: Cisco Technology, Inc.
    Inventors: M. David Hanes, Gonzalo A. Salgueiro, Herbert M. Wildfeuer, Brooks Stevens Read
  • Patent number: 8883998
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for MYD88.
    Type: Grant
    Filed: March 20, 2013
    Date of Patent: November 11, 2014
    Assignee: Thermo Fisher Scientific Inc.
    Inventors: Anastasia Khvorava, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Publication number: 20140228251
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for CTNNB1.
    Type: Application
    Filed: February 12, 2013
    Publication date: August 14, 2014
    Applicant: DHARMACON, INC.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Publication number: 20140148362
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for TTR.
    Type: Application
    Filed: December 5, 2013
    Publication date: May 29, 2014
    Applicant: Thermo Fisher Scientific Biosciences Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Publication number: 20140094390
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed.
    Type: Application
    Filed: December 6, 2013
    Publication date: April 3, 2014
    Applicant: Thermo Fisher Scientific Biosciences Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Publication number: 20140055449
    Abstract: Embodiments of the present invention comprise electronic projection systems and methods. One embodiment of the present invention comprises a method of creating composite images with a projection system comprising as first projector and at least a second projector, comprising generating a correspondence map of pixels for images by determining offsets between pixels from at least a second image from the second projector and corresponding pixels from a first image from the first projector, receiving a source image, warping the source image based at least in part on the correspondence map to produce a warped image, and displaying the source image by the first projector and displaying the warped image by the second projector to create a composite image.
    Type: Application
    Filed: September 6, 2013
    Publication date: February 27, 2014
    Applicant: IMAX Corporation
    Inventors: Matthew O'Dor, Steven Read, Anton Baljet, Philip Insull
  • Patent number: 8658784
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for APP.
    Type: Grant
    Filed: July 18, 2012
    Date of Patent: February 25, 2014
    Assignee: Thermo Fisher Scientific Biosciences Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Patent number: 8658785
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed.
    Type: Grant
    Filed: October 9, 2012
    Date of Patent: February 25, 2014
    Assignee: Thermo Fisher Scientific Biosciences Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read
  • Patent number: 8633306
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: January 21, 2014
    Assignee: Thermo Fisher Scientific Biosciences Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Patent number: 8575329
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for KDR.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: November 5, 2013
    Assignee: Thermo Fisher Scientific Biosciences Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Patent number: 8567953
    Abstract: Embodiments of the present invention comprise electronic projection systems and methods. One embodiment of the present invention comprises a method of creating composite images with a projection system comprising a first projector and at least a second projector, comprising generating a correspondence map of pixels for images by determining offsets between pixels from at least a second image from the second projector and corresponding pixels from a first image from the first projector, receiving a source image, warping the source image based at least in part on the correspondence map to produce a warped image, and displaying the source image by the first projector and displaying the warped image by the second projector to create a composite image.
    Type: Grant
    Filed: April 26, 2006
    Date of Patent: October 29, 2013
    Assignee: IMAX Corporation
    Inventors: Matthew O'Dor, Steven Read, Anton Baljet, Philip Insull
  • Publication number: 20130225447
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for APOB.
    Type: Application
    Filed: April 22, 2013
    Publication date: August 29, 2013
    Applicant: DHARMACON, INC.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Publication number: 20130225667
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for CDKN1B.
    Type: Application
    Filed: April 22, 2013
    Publication date: August 29, 2013
    Applicant: DHARMACON, INC.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Publication number: 20130210676
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for MYD88.
    Type: Application
    Filed: March 20, 2013
    Publication date: August 15, 2013
    Applicant: DHARMACON, INC.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Patent number: 8461326
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to CTGF.
    Type: Grant
    Filed: February 14, 2012
    Date of Patent: June 11, 2013
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Patent number: 8445667
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for CDKN1B.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: May 21, 2013
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Patent number: 8445668
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for APOB.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: May 21, 2013
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Patent number: 8441669
    Abstract: In one embodiment, an originating gateway receives a call menu (CM) signal from an originating fax machine. The CM signal may have been generated in response to an ANSam signal from a terminating fax machine. The originating gateway suppresses the CM signal after a preamble of the CM signal and generates a modified JM signal in response to receiving the CM signal. The modified JM signal indicates that V.34 half-duplex modulation is not an option. The originating gateway transmits the modified JM signal to the originating fax machine, which allows the transmission to continue across an unenhanced T.38 fax relay.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: May 14, 2013
    Assignee: Cisco Technology, Inc.
    Inventors: Hanh Huu Luong, Brooks Stevens Read
  • Patent number: 8426579
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for MYD88.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: April 23, 2013
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Patent number: 8399654
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for CTNNB1.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: March 19, 2013
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe